| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 661205 | Null | 0.00640068043275774 | 0.41022421 |
| NSC 664701 | Null | 0.00640068043275774 | 0.42770361 |
| NSC 667909 | Null | 0.00640068043275774 | 0.19248014 |
| NSC 685285 | Null | 0.00640068043275774 | -0.033296685 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.00640068043275774 | 0.32297772 |
| NSC 728078 | 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide | 0.00640068043275774 | 0.16044411 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.00640068043275774 | 0.027543269 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.00640068043275774 | 0.29351858 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.00640068043275774 | 0.30226295 |
| NSC 743532 | Null | 0.00640068043275774 | -0.043365925 |